谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

SB-4826, a first-in-class oral, covalent inhibitor of SUMO E1 that induces IFN signaling and inhibits tumor growth as monotherapy and in combination with immune checkpoint blockade

Jude R. Canon, Ashley Callinan,Sarah Bradley,Laurie Wang, Mackenzie Kui, Ariel Wein, Gabriele Sulli, Peter Buchowiecki,Fang-Tsao Hong, Miles Kubota,Mary Walton,Victor J. Cee

CANCER RESEARCH（2023）

引用 0|浏览7
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要